Member Info for HighFin1

L

https://www.independent.co.uk/news/health/h3n2-superflu-virus-symptoms-nhs-hospitals-children-b2884157.html

Yes, great lesson.

Do not invest in a company in which the CEO (or other members of the MT) dont own a single share.

Even worse, don't own shares in a company in which the CEO is lying about being interested in shares of his own company.

He is probably awaiting a placing for the expected takeover which he talked about in the investor presentation. That will be a good way for him to scoop up some cheap shares.

Or he will just remain uninvested and come op with 101 different reasons every next AGM (for as long the cash lasts).

i doubt this **** shed will make money from it.

Buy side seems to be back again.

"NHS leaders warning the country is facing an unprecedented flu season"

https://www.bbc.com/news/articles/c74xqn2zg1eo

A potential revenue boost? Given that a quarter of Novacyt revenue is made in the UK

I've send an E-mail multiple times about this. 5 times no reaction and 1 with the text:

"Whilst we appreciate the importance shareholders place on director alignment through share ownership, it's important to recognise that any decision to invest in the Company’s shares is a personal one."

It's a f*cking joke. When Rees was asked previous AGM he said he wasn't able to purchase shares because the MT was in a closed period. Now a year later, even 2 months ago he said he'll be buying, still not a single share was purchased.

Says enough

Cool indeed.

Main question remains: will it make money?

The market isn't convinced yet as the share price is trading near a multi year (post covid all time) low.

Back in the day new product launches were rewarded with a higher share price.

Now however the buy side seems to be completely gone

According to the latest investor presentation Lyn mentioned he'll be buying Shares.

Question is...... When??

''With the WHO announcing the outbreak of Rift Valley fever in Mauritania and Senegal this week, again, the company is in a position to assist if needed''

Primerdesign's revenue in Africa went from 193k in the first six months of 2024 to 115k in the first six months of 2025.

So not only did they not make any revenue from Mpox testing kits, revenue halved in 1 year in this region.

IMO these diseases only become ''interesting'' if they will start spreading in the EU/ Asia where they do make a decent amount of revenue.

Dont expect any revenue, even if Mpox will go full blown pandemic.

They did not even manage to grow Primerdesign's revenue by 1% since the Mpox outbreak in august 2024.

I believe you mate.

Well, at least it is a sign of hope in these dark days. Mpox and H5N1 still raging so maybe some speculation coming up.

Don't see that one at the NCYT share trades page. It will probably show up tomorrow then

Define large

Everyone except Lyn rees

Up 250% today.

It can be done!

Sounds great.

Just hoping that Novacyt will put all of it's efforts towards winning these contracts.

The two ladies in the investor presentation looked and talked quite intelligent. Maybe they can get their foot between the door at NHS.

Where exactly KKT? I did not hear it

Https://youtu.be/Jc5kHZVhmr8?si=nNWNTSHWUi0FURBJ

7:40 "this business is no longer a pandemic company"

"As an investor myself, i would not invest in a business in the expectation that there will be another pandemic"

Word is out. Lyn is not going to invest in Novacyt.